Table 2 Blood lipids and body iron parameters measured at 0-weeks and at 15-weeks resistance training (RT).

	Control (n = 21)		P-value	All-RT (n = 21)		P-value	Compliant-RT (n = 15)		P-value
	0 weeks	15 weeks	P-value	0 weeks	15 weeks	P-value	0 weeks	15 weeks	P-value
TC (mmol/L)	6.2 (5.7–6.8)	6.0 (5.5–7.0)	0.66	6.0 (5.1–6.7)	5.8 (4.6–6.8)	0.13	5.6 (4.8–6.6)	5.3 (4.4–6.5)	0.03*
LDL (mmol/L)	3.6 (3.2–4.2)	3.8 (3.0–4.3)	0.93	3.4 (2.7–4.1)	3.1 (2.4–4.3)	0.24	2.9 (2.6–4.1)	2.9 (2.4–4.1)	0.04*
HDL (mmol/L)	1.8 (1.6–2.5)	2.2 (1.5–2.6)	0.98	1.9 (1.6–2.2)	2.0 (1.6–2.4)	0.86	1.8 (1.5–2.2)	1.8 (1.6–2.4)	0.97
TG (mmol/L)	0.9 (0.7–1.4)	0.9 (0.8–1.6)	0.47	1.0 (0.7–1.6)	1.2 (0.8–1.4)	0.42	1.0 (0.7–1.7)	1.2 (0.8–1.4)	0.18
Non-HDL (mmol/L)	4.1 (3.6–4.8)	4.3 (3.4–4.9)	0.84	3.8 (3.1–4.8)	3.5 (2.9–4.9)	0.10	3.3 (3.0–5.1)	3.2 (2.8–4.8)	0.02*
Apo-A1 (g/L)	1.8 (1.5–2.0)	1.7 (1.6–2.0)	0.85	1.8 (1.6–2.0)	1.7 (1.6–2.0)	0.87	1.8 (1.6–2.0)	1.7 (1.5–1.9)	0.21
Apo- B (g/L)	1.2 (1.0–1.3)	1.1 (0.9–1.2)	0.72	1.1 (0.9–1.3)	1.1 (0.9–1.3)	0.13	1.0 (0.8–1.3)	1.0 (0.8–1.3)	0.07
Ferritin (µg/L)	120 (61–163)	96 (68–157)	0.55	100 (51–147)	86 (44–139)	0.01*	70 (42–141)	65 (18–118)	0.02*
Iron	17 (14–19)	16 (14–20)	0.72	17 (13–21)	17 (14–21)	0.71	18 (12–24)	17 (15–22)	0.82
TF	2.5 (2.3–2.75)	2.6 (2.3–2.8)	0.95	2.5 (2.3–2.7)	2.6 (2.3–2.8)	0.84	2.6 (2.3–2.7)	2.7 (2.2–2.9)	0.93
TF-saturation (%)	27 (20–31)	26 (21–33)	0.98	29 (23–34)	26 (21–33)	0.17	31 (23–36)	26 (22–36)	0.23

Wilcoxon-signed rank tests was used to compare measured parameters across the 15-week study period.
Values are median (quartile range: Q1–Q3); values to be considered significant are displayed in bold text, with *p < 0.05.
Apo – apolipoprotein; HDL – high-density lipoprotein; LDL – low-density lipoprotein; RT – resistance training; TC – total cholesterol; TF – transferrin; TG – triglycerides.

Search